Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rossing

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.
Kidney International. Supplement|June 1, 2000
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathyH Bos, S Andersen, P Rossing, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 25, 2001
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitusP Rossing, L Breum, A Major-Pedersen, et al.
Diabetologia|May 1, 1992
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathyE Hommel, P Andersen, M A Gall, et al.
Diabetes|June 1, 1997
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDML Tarnow, F Pociot, P M Hansen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathyH H Parving, U M Smidt, E Hommel, et al.
Journal of Diabetes and Its Complications|February 4, 2018
Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetesS A Peeters, L Engelen, J Buijs, et al.
Diabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 26, 2018
Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case-control studyJ L Isaksen, C Graff, C Ellervik, et al.
Diabetologia|November 1, 2012
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetesS Alkayyali, M Lajer, H Deshmukh, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.
Kidney International. Supplement|June 1, 2000
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathyH Bos, S Andersen, P Rossing, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 25, 2001
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitusP Rossing, L Breum, A Major-Pedersen, et al.
Diabetologia|May 1, 1992
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathyE Hommel, P Andersen, M A Gall, et al.
Diabetes|June 1, 1997
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDML Tarnow, F Pociot, P M Hansen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathyH H Parving, U M Smidt, E Hommel, et al.
Journal of Diabetes and Its Complications|February 4, 2018
Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetesS A Peeters, L Engelen, J Buijs, et al.
Diabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 26, 2018
Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case-control studyJ L Isaksen, C Graff, C Ellervik, et al.
Diabetologia|November 1, 2012
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetesS Alkayyali, M Lajer, H Deshmukh, et al.
Pageof 14